Skip to main
  1. Stocks
  2. Medical Properties Trust Inc
  3. Forecast
MPT

MPT Stock Forecast & Price Target

MPT Analyst Ratings

Based on 2 analyst ratings
Sell
Strong Buy 0%
Buy 0%
Hold 0%
Sell 100%
Strong Sell 0%

Bulls say

Medical Properties Trust is viewed favorably because its long-term, net-leased healthcare portfolio can benefit from a rebound in hospital operating conditions and tenant coverage, which would strengthen rent collection and improve the durability of cash flows. The analysis also points to meaningful embedded asset value, with in-place NAV estimated at $2.14/share and potential to rise to $2.77/share at YE26E and $4.00/share at YE27E if underperforming assets and former Steward, Prospect, and Priory properties recover value. In addition, monetizing zero- or under-earning properties and refinancing $587 million of 2026 debt and $1.6 billion of 2027 debt could reduce balance-sheet pressure and unlock upside.

Bears say

Medical Properties Trust is facing a fundamentally कमजोर outlook because tenant distress, especially at HSA and Priory, is pressuring rent collections and forcing lease restructuring, while rent recovery remains uncertain and near-term working capital support may not be repaid quickly. Its earnings power is also being diluted by expensive refinancing, as $2.4 billion of secured debt at 9.25% replaced bonds yielding about 3.7%, and estimates were cut to $0.44/share in 2026, $0.27/share in 2027, and $0.26/share in 2028. With only about $216 million of cash net of LOC balances against $94 million of committed developments and an estimated cash burn rate of roughly $160 million in 2027 and 2028, elevated leverage and tight liquidity leave little margin for error.

MPT has been analyzed by 2 analysts, with a consensus rating of Sell. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 100% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medical Properties Trust Inc and is not a guaranteed prediction by Public.com or investment advice.

MPT Analyst Forecast & Price Prediction

Get the latest MPT stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MPT

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medical Properties Trust Inc (MPT) Forecast

Analysts have given MPT a Sell based on their latest research and market trends.

According to 2 analysts, MPT has a Sell consensus rating as of Nov 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.90, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.90, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medical Properties Trust Inc (MPT)


MPT Analyst Forecast & Price Prediction

Get the latest MPT stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MPT

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover MPT stock data and trends